156 related articles for article (PubMed ID: 6769527)
1. Behavioural changes induced by N,N-dimethyl-tryptamine in rodents.
Jenner P; Marsden CD; Thanki CM
Br J Pharmacol; 1980 May; 69(1):69-80. PubMed ID: 6769527
[TBL] [Abstract][Full Text] [Related]
2. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
Green AR; Hall JE; Rees AR
Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
[TBL] [Abstract][Full Text] [Related]
3. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.
Costain DW; Green AR
Br J Pharmacol; 1978 Oct; 64(2):193-200. PubMed ID: 30503
[TBL] [Abstract][Full Text] [Related]
4. Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systems.
Luscombe G; Jenner P; Marsden CD
Neuropharmacology; 1982 Dec; 21(12):1257-65. PubMed ID: 6130489
[TBL] [Abstract][Full Text] [Related]
5. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
Deakin JF; Green AR
Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
[TBL] [Abstract][Full Text] [Related]
6. A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.
Dourish CT
Br J Pharmacol; 1982 Sep; 77(1):129-39. PubMed ID: 6982090
[TBL] [Abstract][Full Text] [Related]
7. Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice.
Morinan A; Collier JG
Psychopharmacology (Berl); 1981; 75(2):179-83. PubMed ID: 6798607
[TBL] [Abstract][Full Text] [Related]
8. beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responses.
Cowen PJ; Grahame-Smith DG; Green AR; Heal DJ
Br J Pharmacol; 1982 Jun; 76(2):265-70. PubMed ID: 6124294
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological studies on serotonin-mediated behaviour.
Green AR
J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143
[TBL] [Abstract][Full Text] [Related]
10. Effect of tryptamine on the behavior of mice.
Sugimoto Y; Yamada J; Horisaka K
J Pharmacobiodyn; 1986 Jan; 9(1):68-73. PubMed ID: 2940357
[TBL] [Abstract][Full Text] [Related]
11. Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigs.
Luscombe G; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Jun; 32(12):1857-64. PubMed ID: 6192824
[TBL] [Abstract][Full Text] [Related]
12. The effects of lesions produced by 5,7-dihydroxytryptamine on 5-hydroxytryptamine-mediated behaviour induced by amphetamine in large doses in the rat.
Dickinson SL; Andrews CD; Curzon G
Neuropharmacology; 1984 Apr; 23(4):423-9. PubMed ID: 6728129
[TBL] [Abstract][Full Text] [Related]
13. The behavioural effects of intravenously administered tryptamine in mice.
Yamada J; Sugimoto Y; Horisaka K
Neuropharmacology; 1987 Jan; 26(1):49-53. PubMed ID: 3561719
[TBL] [Abstract][Full Text] [Related]
14. Behavioral effects and metabolic fate of N,N-dimethyltryptamine in mice pretreated with beta-diethylaminoethyl-diphenylpropylacetate (SKF 525-A), improniazid and chlorpromazine.
Shah NS; Hedden MP
Pharmacol Biochem Behav; 1978 Apr; 8(4):351-6. PubMed ID: 276891
[TBL] [Abstract][Full Text] [Related]
15. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
Green AR; DeSouza RJ; Davies EM; Cross AJ
Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
[TBL] [Abstract][Full Text] [Related]
16. Disruption of conditioned avoidance behavior by n,n-dimethyltryptamine (DMT) and stereotype by beta-phenylethylamine (PEA): animal models of attentional defects in schizophrenia.
Stoff DM; Moja EA; Gillin JC; Wyatt RJ
J Psychiatr Res; 1978; 14(1-4):225-40. PubMed ID: 281530
[No Abstract] [Full Text] [Related]
17. Evidence that 5-methoxy-N, N-dimethyl tryptamine is a specific substrate for MAO-A in the rat: implications for the indoleamine dependent behavioural syndrome.
Squires RF
J Neurochem; 1975 Jan; 24(1):47-50. PubMed ID: 1053788
[No Abstract] [Full Text] [Related]
18. Sex differences in behavioral and thermal responses to pargyline and tryptophan.
Biegon A; Segal M; Samuel D
Psychopharmacology (Berl); 1979 Mar; 61(1):77-80. PubMed ID: 108723
[TBL] [Abstract][Full Text] [Related]
19. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
20. Behavioural changes induced by N,N-dimethyltryptamine in rodents [proceedings].
Jenner P; Marsden CD; Thanki CM
Br J Pharmacol; 1978 Jun; 63(2):380P. PubMed ID: 276408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
